Latest filings (excl ownership)
15-12G
Securities registration termination
16 May 16
EFFECT
Notice of effectiveness
11 May 16
EFFECT
Notice of effectiveness
11 May 16
8-K
SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction
9 May 16
8-K
Entry into a Material Definitive Agreement
9 May 16
POS AM
Prospectus update (post-effective amendment)
9 May 16
POS AM
Prospectus update (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
9 May 16
25-NSE
Exchange delisting
6 May 16
425
Business combination disclosure
2 May 16
8-K
VBI Vaccines to Present at the Bloom Burton Healthcare
28 Apr 16
425
Business combination disclosure
14 Apr 16
8-K
VBI Vaccines and SciVac Therapeutics Announce Effectiveness of Registration Statement on Form F-4
14 Apr 16
DEF 14A
Definitive proxy
8 Apr 16
8-K
Other Events
30 Mar 16
8-K
VBI Vaccines to Present at the World Vaccine Congress Washington
29 Mar 16
8-K
Entry into a Material Definitive Agreement
21 Mar 16
CT ORDER
Confidential treatment order
14 Mar 16
CT ORDER
Confidential treatment order
14 Mar 16
8-K
VBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference
7 Mar 16
425
Business combination disclosure
3 Mar 16
8-K
VBI Vaccines to Present at the ROTH Conference
3 Mar 16
8-K
Entry into a Material Definitive Agreement
2 Mar 16
10-K
2015 FY
Annual report
26 Feb 16
8-K
Entry into a Material Definitive Agreement
9 Feb 16
8-K
VBI Vaccines Partners with the Canadian CMV Foundation to Raise Congenital Cytomegalovirus Awareness
4 Feb 16
425
Business combination disclosure
26 Jan 16
8-K
VBI Vaccines to Present at the BIO CEO & Investor Conference
26 Jan 16
425
Business combination disclosure
15 Jan 16
8-K
VBI Vaccines to Present at the Noble Financial Emerging
15 Jan 16
425
Business combination disclosure
22 Dec 15
8-K
Entry into a Material Definitive Agreement
22 Dec 15
8-K
Entry into a Material Definitive Agreement
11 Dec 15
425
Business combination disclosure
25 Nov 15
8-K
VBI Vaccines to Present at the LD Micro Conference
25 Nov 15
8-K
VBI Vaccines Presents Update and New Data Supporting its Glioblastoma Immunotherapy Program at the ESMO Symposium on Immuno-Oncology
20 Nov 15
Latest ownership filings
SC 13D/A
ARCH VENTURE FUND VI LP
25 Jul 23
SC 13D/A
ARCH VENTURE FUND VI LP
6 May 20
SC 13G/A
Vbi Vaccines Inc.
12 Feb 20
4
STEVEN GILLIS
23 Sep 19
SC 13G/A
Vbi Vaccines Inc.
11 Feb 19
SC 13G
Vbi Vaccines Inc.
29 May 18
SC 13D/A
Vbi Vaccines Inc.
9 Feb 18
3
Jeff Baxter
19 Apr 17
3
Michel DeWilde
19 Apr 17
4
Michel DeWilde
19 Apr 17
4
Jeff Baxter
19 Apr 17
SC 13D
Vbi Vaccines Inc.
31 Mar 17
4/A
JOSEPH EDELMAN
9 Mar 17
SC 13D/A
Vbi Vaccines Inc.
9 Mar 17
SC 13D
Vbi Vaccines Inc.
10 Feb 17
SC 13G/A
Vbi Vaccines Inc.
10 Feb 17
SC 13D
Vbi Vaccines Inc.
12 Dec 16
4
JOSEPH EDELMAN
8 Dec 16
SC 13G/A
Vbi Vaccines Inc.
26 May 16
SC 13G
Vbi Vaccines Inc.
16 Feb 16
SC 13G/A
Vbi Vaccines Inc.
11 Feb 16
SC 13D/A
Beneficial ownership report (amended)
9 Feb 16
SC 13G/A
Vbi Vaccines Inc.
5 Feb 16
SC 13G/A
Vbi Vaccines Inc.
23 Nov 15
SC 13D/A
Vbi Vaccines Inc.
24 Aug 15
4
JOSEPH EDELMAN
18 Aug 15
3/A
STEVEN GILLIS
17 Aug 15
3/A
ROBERT NELSEN
17 Aug 15
4
STEVEN GILLIS
17 Aug 15
4
ROBERT NELSEN
17 Aug 15
4
TRENT D DAVIS
5 Aug 15
4
David Evander Anderson
5 Aug 15
4
ALAN P TIMMINS
5 Aug 15
4
Jeff Baxter
5 Aug 15
4
Egidio Nascimento
5 Aug 15
4
Michel DeWilde
5 Aug 15
4
MICHAEL STEINMETZ
5 Aug 15
4
SAM CHAWLA
5 Aug 15
4
T. Adam Buckley
5 Aug 15
4
STEVEN GILLIS
5 Aug 15